Skip to main content

Alzheimer’s Therapeutics Market Area And Industry Forecasts Till, 2014 - 2025

Alzheimer’s disease is a progressive, non-reversible, and neurodegenerative disorder. Alzheimer is caused due to abnormal functioning of brain cells. It is the most common form of dementia. In simple words, it is a biological disease marked by physical changes in the brain and most remarkably build-up of small protein clumps called “Tangles” and “Plaques” that lead to the death of nerve cells.

The factors that propel the growth of the Alzheimer’s therapeutics market include well-developed healthcare infrastructure, high consciousness levels, increase in incidence of neurodegenerative diseases, growing aged population, and increasing R&D investment. On the other hand, there are factors that may hamper the growth of the market including lack of transparent reimbursements, high cost of treatment and diagnosis in the later stage, typically owing to delayed appearance of symptoms.

Download Free Sample  - https://www.millioninsights.com/industry-reports/alzheimers-therapeutics-market/request-sample

The new product launches and research collaborations are some of the key strategies adopted by the top industry players. For instance, Actavis plc in collaboration with Adamas Pharmaceuticals Inc. lately publicized the US FDA approval of Namzaric, a fixed-dose combination of donepezil and memantine. The drug is likely to be launched in the first half of year 2015. Additionally, in Jan 2015, Johnson & Johnson signed a research deal with a Swiss biotech firm AC Immune, to change anti-tau Alzheimer's vaccines.

Alzheimer’s therapeutics industry is anticipated to expand at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. Alzheimer’s therapeutics market could be explored by therapeutic type, application and geography. The market could be explored by therapeutic type as N-methyl-D-aspartate (NMDA) receptor antagonist and Cholinesterase Inhibitors. The “Cholinesterase Inhibitors” segment led the Alzheimer’s therapeutics industry in 2016 and is anticipated to maintain its dominance by 2024. The key applications that could be explored in the Alzheimer’s therapeutics market include Moderate to severe Stages, and Early to Moderate Stages.

North America accounted for the major share of the Alzheimer’s therapeutics industry in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing prevalence of Alzheimer’s disease, growing aged population, extensive technological advancements in the region, high awareness levels, and strong healthcare infrastructure. North America is likely to be followed by Europe.

Comments

Post a Comment

Popular posts from this blog

Thermal Spray Coatings Market Share & Scope, Product Estimates & Strategy Framework To 2013 - 2024

Thermal spray coating refers to industrial process that involves coating material in wire or powder form and a heat source. The heat source is used to melt the material into tiny droplets, which are sprayed onto substrates at high velocity. This technique is able to improve performance characteristics of the substrates by imparting erosion, wear, corrosion, heat, cavitation, and abrasion. Other advantages include high deposition rate, thick coatings, and low toxic gas emissions. Growing need to enhance durability of machines among industries to reduce maintenance costs is anticipated to propel thermal spray coatings industry growth. Changing consumer preference for thermal spray coatings over chrome plating owing to superior properties is expected to impel market growth. Stringent regulations introduced by governments across various nations to reduce use of material containing volatile organic compounds (VOCs) will drive the thermal spray coatings market over the forecast period. Downl
Post a Comment
Read more

Global DHA from Algae Market Size Comparison by Application (2013-2028)

    The global DHA from Algae market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for DHA from Algae from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the DHA from Algae market. Download Free Sample  -  https://www.radiantinsights.com/research/2013-2028-report-on-global-dha-from-algae-market/request-sample Leading players of DHA from Algae including: DSM Lonza Cellana JC Biotech FEMICO Runke Bioco CABIO Fuxing Huison Kingdomway Amry Yuexiang Keyuan Market split by Type, can be divided into: Triglyceride Type Ester Type Ethyl Ester Type Market split by Application, can be divided into: Infant Formula Nutritional Supplements Fo
Post a Comment
Read more

Cyclospora Diagnostic Testing Market Size & Forecast Report, 2014 - 2025

Cyclospora is basically an intestinal ailment that is affected via the microscopic parasite termed as “Cyclospora cayetanensis”. Cyclospora Diagnostic Testing Market size on the basis of end-users spans commercial or private laboratories, hospitals, public health labs and physician offices. It is a single-celled coccidian parasitic pathogen that triggers intestinal infection that leads to diarrhea. When we look at it in the medical terms, this diarrheal infection is labeled as cyclospora infection (cyclosporiasis). It is known that this particular infection is usually spread and communicated via feces and ingestion of food and water infected with sporulated oocysts. Download Free Sample  -  https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market/request-sample Through studies, it has been found that people can be infected with Cyclospora by taking in food or water that is polluted and tainted with the parasite. Those people are at great risk for infection
Post a Comment
Read more